Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial - Concepedia

Concepedia

Publication | Open Access

Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial

DOI Full Paper Access

96

Citations

30

References

2015

Year

Lionel Rostaing, Suphamai Bunnapradist, Josep M. Grinyó, Kazimierz Ciechanowski, Jason Denny, Hélio Tedesco‐Silva, Klemens Budde, Jason Denny, Sanjay Kulkarni, Donald E. Hricik,

American Journal of Kidney Diseases

Abstract

Results suggest that once-daily LCPT in de novo kidney transplantation has comparable efficacy and safety profile to that of IR-Tac. Lower TDD reflects LCPT's improved bioavailability and absorption.

References

	Year	Citations

Page 1